2397 — DNA Chip Research Cashflow Statement
0.000.00%
Last trade - 00:00- ¥7bn
- ¥7bn
- ¥1bn
Annual cashflow statement for DNA Chip Research, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -172 | -133 | -361 | -246 | -55.4 |
| Depreciation | |||||
| Non-Cash Items | 1.31 | 11.8 | 24.5 | 3.08 | 96.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 72.6 | 31.8 | -18 | 61.2 | -14.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -76 | -73 | -337 | -140 | 84.1 |
| Capital Expenditures | -51.4 | -58.7 | -126 | -15.9 | -58.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | -29.3 | 0.085 | -2.85 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -51.4 | -58.7 | -155 | -15.8 | -61.2 |
| Financing Cash Flow Items | -0.001 | — | — | — | -0.561 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 446 | — | 278 | 269 | -0.632 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 318 | -132 | -214 | 113 | 22.2 |